STOCKHOLM, May 19, 2023 /PRNewswire/ — Sobi today announced that the European Medicines Agency (EMA) has accepted and validated a marketing authorisation application for efanesoctocog alfa, a new class of high-sustained FVIII developed for the treatment of people with haemophilia A of all age groups. The application is based on data from the pivotal XTEND-1 … Read more
PARIS, May 19, 2023 /PRNewswire/ — On May 17th 2023, the six-month result of the SMART Study (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) was released on the Late Breaking Clinical Trial conference, reporting ground-breaking findings in the field of hypertension. With Professor Huo Yong as the leading investigator and SyMap Medical (Suzhou) … Read more
DUBLIN, May 18, 2023 /PRNewswire/ — The “Foam Dressings: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Foam Dressings Market to Reach $3.2 Billion by 2030 The global market for Foam Dressings estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by … Read more
NEW YORK, May 18, 2023 /PRNewswire/ — The human combination vaccines market size is set to grow by USD 6046.98 million between 2022 and 2027 and register a CAGR of 8.13%, according to Technavio’s latest market research report. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by way of synthesis, and … Read more
If approved by the U.S. Food and Drug Administration, this newly designed, low-dose copper IUD could be the first hormone-free IUD in almost 40 years ROSWELL, Ga., May 18, 2023 /PRNewswire/ — Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced positive results of a Phase 3 study demonstrating that investigational Copper 175 … Read more
CHARLOTTESVILLE, Va., May 18, 2023 /PRNewswire/ — HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, participated in the Piper Sandler Spring Biopharma Symposium being held in Boston, MA, Wednesday, May 17 through Thursday, May 18, 2023. The HemoShear management team, led by Brian Wamhoff, Interim CEO, briefed institutional investors on the latest company … Read more
Data is being presented at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting MARLBOROUGH, Mass., May 18, 2023 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced pre-clinical data … Read more
Curae Pharma360 Applauds the House Energy and Commerce Committee for Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains SAN FRANCISCO, May 18, 2023 /PRNewswire/ — On May 11, the House Energy and Commerce Committee held a timely and important hearing to identify and raise visibility for the root causes of … Read more
The publication in PLOS ONE shows that NAV-001 has robust single-dose efficacy against multiple mesothelin-expressing cancers and that tumor-produced Humoral Immunology-Oncology (HIO) factors negatively impact antibody drug internalization and efficacy. CHEYNEY, Pa., May 18, 2023 /PRNewswire/ — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announces today a publication describing … Read more
NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more